Delivery Order SPE2DB20D1100-SPE2DB25FA1V7
Award Date
1/21/25
Potential Completion Date
1/22/25
Potential Value
$1.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with ID SPE2DB20D1100|SPE2DB25FZ34U, was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,594,726 units of Ondansetron HCL 4 mg Tablets, a medication used to prevent nausea and vomiting. The contract has a ceiling value of $4,675.12 and a completion date of December 4, 2024. This appears to be a Firm Fixed Price Delivery Order...
This federal contract award, valued at $22,819.04, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,037,797 units of Ondansetron HCL 4 mg tablets, a medication used to treat nausea and vomiting. The contract type is a Delivery Order with a Firm Fixed Price pricing mechanism and an ultimate completion date of January 27, 2025. This contract award is not...
This federal contract award, valued at $3,518.49, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,564,793,731 tablets of Ondansetron HCL 4 mg, a medication used to prevent nausea and vomiting. The contract is a Firm Fixed Price Delivery Order, with a period of performance through June 4, 2024. This award is part of a larger Indefinite Delivery Contract...
This federal contract award, with the ID SPE2DB22D3011|SPE2DB25FP9DX, is a Delivery Order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,138,858 units of Ondansetron HCL 4 MG Tablets, a medication used to treat nausea and vomiting. The contract has a Firm Fixed Price pricing type and a ceiling value of $2,305.52. The award date is February 3, 2025, and the...
This federal contract award, with ID SPE2DB20D1109|SPE2DB25FN07K, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,404,006 units of Ondansetron ODT 4 mg tablets, a medication used to treat nausea and vomiting. The contract has a ceiling value of $1,720.56 and is a Firm Fixed Price Delivery Order, with a period of performance through November 13, 2024....
This federal contract award, with ID SPE2DB22D3011|SPE2DB25FP8NH, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,907,253 units of Ondansetron ODT 4 mg tablets, a medication used to prevent nausea and vomiting. The award has a ceiling value of $3,018.12 and a completion date of January 14, 2025. This appears to be a delivery order under a larger...
This federal contract award, valued at $10,038.08, was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,254,639 units of 4 mg Ondansetron HCL tablets, a medication used to prevent nausea and vomiting. The contract is a Firm Fixed Price Delivery Order with a completion date of February 13, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This federal contract award, valued at $1,163.88, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order contract for the supply of Ondansetron HCL 4 mg tablets, a medication used to prevent nausea and vomiting. The contract has a firm fixed-price pricing type and an ultimate completion date of March 12, 2024. The contract is not designated with a set-aside requirement,...
This federal contract award, worth $7,798.14, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,153,745 units of Ondansetron ODT 4 mg tablets, a medication used to treat nausea and vomiting. This is a firm-fixed-price delivery order contract, with a completion date of February 5, 2025. The contract is not designated as a set-aside award. In addition to...
This federal contract award, valued at $2,848.39, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,564,803,693 units of Ondansetron ODT 4 mg tablets, a medication commonly used to treat nausea and vomiting. The contract has a firm fixed-price pricing type and an ultimate completion date of June 5, 2024. This contract award is part of a larger Indefinite...